Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Willis

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Neurology|May 19, 2017
Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesisM D Willis, N P Robertson
Journal of Neurology|July 12, 2018
Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical diseaseM D Willis, N P Robertson
Journal of Neurology|April 19, 2020
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2M D Willis, N P Robertson
Journal of Neurology|August 27, 2013
Amyotrophic lateral sclerosis: new hope for an old disease?M D Willis, N P Robertson
Journal of Neurology|June 23, 2014
Treatment paradigms in multiple sclerosis: who, when and how to treat?M D Willis, N P Robertson
Journal of Neurology|October 8, 2020
Multiple sclerosis: early indicators of disease and assessing future riskM D Willis, N P Robertson
Journal of Neurology|February 14, 2019
Technology-assisted recovery of walking after spinal cord injuryM D Willis, N P Robertson
Journal of Neurology|June 30, 2019
Neurotoxicity of novel cancer immunotherapiesM D Willis, N P Robertson
Journal of Neurology|August 29, 2018
Correction to: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical diseaseM D Willis, N P Robertson
Journal of Neurology|November 5, 2024
Chimeric antigen receptor T cell (CAR-T) therapy in neurological diseaseO Gbadegesin, P Prasad, M D Willis
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Neurology|May 19, 2017
Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesisM D Willis, N P Robertson
Journal of Neurology|July 12, 2018
Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical diseaseM D Willis, N P Robertson
Journal of Neurology|April 19, 2020
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2M D Willis, N P Robertson
Journal of Neurology|August 27, 2013
Amyotrophic lateral sclerosis: new hope for an old disease?M D Willis, N P Robertson
Journal of Neurology|June 23, 2014
Treatment paradigms in multiple sclerosis: who, when and how to treat?M D Willis, N P Robertson
Journal of Neurology|October 8, 2020
Multiple sclerosis: early indicators of disease and assessing future riskM D Willis, N P Robertson
Journal of Neurology|February 14, 2019
Technology-assisted recovery of walking after spinal cord injuryM D Willis, N P Robertson
Journal of Neurology|June 30, 2019
Neurotoxicity of novel cancer immunotherapiesM D Willis, N P Robertson
Journal of Neurology|August 29, 2018
Correction to: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical diseaseM D Willis, N P Robertson
Journal of Neurology|November 5, 2024
Chimeric antigen receptor T cell (CAR-T) therapy in neurological diseaseO Gbadegesin, P Prasad, M D Willis
Pageof 2